Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

04 févr. 2026 08h00 HE | Source: Entera Bio

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to...
13 janv. 2021 06h00 HE | Source: Sian Capital, LLC

Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q’20 Guidance

NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Sian Capital, LLC (together with its affiliates, “Sian” or “we”), a sizable stockholder of OPKO Health, Inc. (NASDAQ: OPK) (“OPKO” or the “Company”),...
12 nov. 2020 18h30 HE | Source: Sian Capital, LLC

Sian Capital Issues Open Letter to Stockholders of OPKO Health

Highlights that Just Two Weeks after Sian Capital Sent Its 220 Demand Letter to OPKO, the Company has Agreed to Release A Subset of the Documents Requested, Which We Believe Will Validate our...
29 oct. 2020 17h20 HE | Source: Sian Capital, LLC

Sian Capital Highlights Paths to Meaningful Value Creation at OPKO Health

Issues Presentation Outlining Viable Paths to Unlocking OPKO’s Intrinsic Value, Which is ~3x the Company’s Current Market Capitalization Based on its Diagnostic and Pharmaceutical Assets Releases...
06 nov. 2018 08h10 HE | Source: Shareholders Foundation, Inc.

November 13th Deadline in Lawsuit for investors in shares of OPKO Health, Inc. (NASDAQ: OPK) announced by Shareholders Foundation

SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline is comping up on November 13th, 2018 in the lawsuit that was filed for certain investors in...